Amylyx Pharmaceuticals (AMLX) Shares Outstanding (2021 - 2026)

Amylyx Pharmaceuticals' Shares Outstanding history runs 6 years deep, the most recent figure standing at $111.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 24.64% year-over-year to $111.0 million; the TTM figure through Mar 2026 stood at $111.0 million (up 24.64% YoY), while the FY2025 annual figure was $109.9 million, up 60.11% from the prior year.
• Shares Outstanding was $111.0 million for Q1 2026 at Amylyx Pharmaceuticals, up from $109.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $111.0 million in Q1 2026 to a low of $57.9 million in Q1 2022.
• Historically, Shares Outstanding has averaged $76.1 million across 5 years, with a median of $68.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding jumped 847.4% in 2022, then increased 1.08% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $66.5 million in 2022, then advanced by 1.8% to $67.7 million in 2023, then gained by 1.36% to $68.6 million in 2024, then soared by 60.11% to $109.9 million in 2025, then rose by 1.04% to $111.0 million in 2026.
• The last three Shares Outstanding figures came in at $111.0 million (Q1 2026), $109.9 million (Q4 2025), and $109.8 million (Q3 2025), per Business Quant data.